Logo image of KINS

KINGSTONE COS INC (KINS) Stock Fundamental Analysis

USA - NASDAQ:KINS - US4967191051 - Common Stock

15.0699 USD
+0.18 (+1.24%)
Last: 10/21/2025, 11:38:58 AM
Fundamental Rating

5

Overall KINS gets a fundamental rating of 5 out of 10. We evaluated KINS against 147 industry peers in the Insurance industry. KINS has an average financial health and profitability rating. KINS has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year KINS was profitable.
In the past year KINS had a positive cash flow from operations.
In multiple years KINS reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: KINS reported negative operating cash flow in multiple years.
KINS Yearly Net Income VS EBIT VS OCF VS FCFKINS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

The Return On Assets of KINS (7.00%) is better than 93.20% of its industry peers.
With an excellent Return On Equity value of 29.04%, KINS belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
The Return On Invested Capital of KINS (7.62%) is better than 90.48% of its industry peers.
Industry RankSector Rank
ROA 7%
ROE 29.04%
ROIC 7.62%
ROA(3y)-1.36%
ROA(5y)-1.2%
ROE(3y)-17.5%
ROE(5y)-12.24%
ROIC(3y)N/A
ROIC(5y)N/A
KINS Yearly ROA, ROE, ROICKINS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

KINS has a better Profit Margin (14.84%) than 79.59% of its industry peers.
KINS's Operating Margin of 19.90% is fine compared to the rest of the industry. KINS outperforms 76.87% of its industry peers.
Industry RankSector Rank
OM 19.9%
PM (TTM) 14.84%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KINS Yearly Profit, Operating, Gross MarginsKINS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

4

2. Health

2.1 Basic Checks

KINS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
KINS has more shares outstanding than it did 1 year ago.
KINS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for KINS has been reduced compared to a year ago.
KINS Yearly Shares OutstandingKINS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
KINS Yearly Total Debt VS Total AssetsKINS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

The Debt to FCF ratio of KINS is 0.07, which is an excellent value as it means it would take KINS, only 0.07 years of fcf income to pay off all of its debts.
KINS's Debt to FCF ratio of 0.07 is amongst the best of the industry. KINS outperforms 92.52% of its industry peers.
A Debt/Equity ratio of 0.05 indicates that KINS is not too dependend on debt financing.
KINS has a better Debt to Equity ratio (0.05) than 81.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.07
Altman-Z N/A
ROIC/WACC0.86
WACC8.84%
KINS Yearly LT Debt VS Equity VS FCFKINS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
KINS Yearly Current Assets VS Current LiabilitesKINS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

7

3. Growth

3.1 Past

KINS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 452.94%, which is quite impressive.
KINS shows a strong growth in Revenue. In the last year, the Revenue has grown by 29.74%.
Measured over the past years, KINS shows a small growth in Revenue. The Revenue has been growing by 1.35% on average per year.
EPS 1Y (TTM)452.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.31%
Revenue 1Y (TTM)29.74%
Revenue growth 3Y-1.27%
Revenue growth 5Y1.35%
Sales Q2Q%43.04%

3.2 Future

KINS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.53% yearly.
Based on estimates for the next years, KINS will show a very strong growth in Revenue. The Revenue will grow by 25.19% on average per year.
EPS Next Y50.85%
EPS Next 2Y28.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year39.52%
Revenue Next 2Y25.19%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
KINS Yearly Revenue VS EstimatesKINS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
KINS Yearly EPS VS EstimatesKINS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1 2

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 8.02 indicates a reasonable valuation of KINS.
KINS's Price/Earnings ratio is a bit cheaper when compared to the industry. KINS is cheaper than 72.11% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.69. KINS is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 6.42 indicates a rather cheap valuation of KINS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of KINS indicates a somewhat cheap valuation: KINS is cheaper than 78.23% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.18, KINS is valued rather cheaply.
Industry RankSector Rank
PE 8.02
Fwd PE 6.42
KINS Price Earnings VS Forward Price EarningsKINS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

KINS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. KINS is cheaper than 80.95% of the companies in the same industry.
82.31% of the companies in the same industry are more expensive than KINS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.08
EV/EBITDA 4.61
KINS Per share dataKINS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
KINS's earnings are expected to grow with 28.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.16
PEG (5Y)N/A
EPS Next 2Y28.53%
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

KINS has a Yearly Dividend Yield of 1.37%. Purely for dividend investing, there may be better candidates out there.
KINS's Dividend Yield is comparable with the industry average which is at 3.31.
Compared to an average S&P500 Dividend Yield of 2.34, KINS's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.37%

5.2 History

KINS has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
KINS Yearly Dividends per shareKINS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2025 0 0 0 0 0

5.3 Sustainability

DP0%
EPS Next 2Y28.53%
EPS Next 3YN/A
KINS Yearly Income VS Free CF VS DividendKINS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

KINGSTONE COS INC

NASDAQ:KINS (10/21/2025, 11:38:58 AM)

15.0699

+0.18 (+1.24%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-06 2025-11-06/amc
Inst Owners48.06%
Inst Owner Change-0.34%
Ins Owners12.76%
Ins Owner Change4.02%
Market Cap213.09M
Analysts85.71
Price Target22.44 (48.91%)
Short Float %9.02%
Short Ratio5.09
Dividend
Industry RankSector Rank
Dividend Yield 1.37%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-11 2025-08-11 (0.05)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.89%
Min Revenue beat(2)-2.9%
Max Revenue beat(2)-2.87%
Revenue beat(4)0
Avg Revenue beat(4)-14.81%
Min Revenue beat(4)-51.81%
Max Revenue beat(4)-1.66%
Revenue beat(8)3
Avg Revenue beat(8)-7.04%
Revenue beat(12)5
Avg Revenue beat(12)-1.59%
Revenue beat(16)7
Avg Revenue beat(16)-0.17%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.15%
EPS NY rev (1m)5%
EPS NY rev (3m)5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 8.02
Fwd PE 6.42
P/S 1.15
P/FCF 3.08
P/OCF 2.97
P/B 2.25
P/tB 2.26
EV/EBITDA 4.61
EPS(TTM)1.88
EY12.48%
EPS(NY)2.35
Fwd EY15.57%
FCF(TTM)4.89
FCFY32.44%
OCF(TTM)5.08
OCFY33.73%
SpS13.13
BVpS6.71
TBVpS6.67
PEG (NY)0.16
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7%
ROE 29.04%
ROCE 9.67%
ROIC 7.62%
ROICexc 8.36%
ROICexgc 10.3%
OM 19.9%
PM (TTM) 14.84%
GM N/A
FCFM 37.23%
ROA(3y)-1.36%
ROA(5y)-1.2%
ROE(3y)-17.5%
ROE(5y)-12.24%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.07
Debt/EBITDA 0.13
Cap/Depr 110.92%
Cap/Sales 1.48%
Interest Coverage 14.75
Cash Conversion 182.28%
Profit Quality 250.89%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score8
WACC8.84%
ROIC/WACC0.86
Cap/Depr(3y)98.26%
Cap/Depr(5y)109.6%
Cap/Sales(3y)2.09%
Cap/Sales(5y)2.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)452.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.31%
EPS Next Y50.85%
EPS Next 2Y28.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)29.74%
Revenue growth 3Y-1.27%
Revenue growth 5Y1.35%
Sales Q2Q%43.04%
Revenue Next Year39.52%
Revenue Next 2Y25.19%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y236.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1070.86%
FCF growth 3Y40.97%
FCF growth 5Y16.49%
OCF growth 1Y1807%
OCF growth 3Y33.51%
OCF growth 5Y14.18%